Interestingly, some of the earliest clinical evidence that IFN dysregulation caused neuropsychiatric symptoms was incidentally discovered during IFN treatment for hepatitis C, hepatitis B, and melanoma (112–114). The gene discussed is IFNA1; the disease is hepatitis B virus infection.